Skip to main content

Patient Support Line 1-800-282-7630, Monday – Friday: 9 AM – 5 PM ET

Financial Resources and Saving Options

We’re committed to making treatment with KISQALI as affordable as possible. What you'll pay for your KISQALI prescription depends on a few factors. Visit the Novartis Oncology Patient Support website to get a better idea of what your cost may be. 

Read below to learn about ways you may be able to save on your KISQALI prescription, and then see how a Patient Navigator can help simplify this process for you.

Free Trial Offer for KISQALI and/or FEMARA

Image of 1 Free Treatment Cycle card. Text says: 1 FREE Treatment Cycle of any of the following: a. KISQALI FERMA Co-Pack. b. KISQALI® (ribociclib). c. FERMARA® (letrozole). d. letrozole. e. KISQALI + FEMARA/ f. KISQALI + letrozole.



Patients are eligible to receive a 1-treatment cycle supply of any one of the following at no cost.

a. KISQALI    
b. FEMARA    
c. letrozole    
e. KISQALI + letrozole    

Call 1-800-282-7630 or visit to receive your free trial offer.

The KISQALI FEMARA Co-Pack is a prescription medicine used as the first hormonal-based therapy to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic).

The KISQALI FEMARA Co-Pack contains 2 different types of medicines:

  • The violet tablet contains the medicine KISQALI.

  • The yellow tablet contains the medicine FEMARA.

It is not known if KISQALI or the KISQALI FEMARA Co-Pack are safe and effective in children.

No purchase required of the KISQALI FEMARA Co-Pack, or KISQALI or FEMARA (including generic letrozole). This offer is available for patients with a valid prescription for the KISQALI FEMARA Co-Pack, or for KISQALI and/or FEMARA (including generic letrozole), including for patients who have not been prescribed KISQALI or another Novartis product.

Important Safety Information

What is the most important information I should know about KISQALI ?

KISQALI may cause serious side effects, including:

Lung problems. KISQALI may cause severe or life-threatening inflammation of the lungs during treatment that may lead to death. Tell your health care provider right away if you have any new or...


KISQALI is a prescription medicine used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has gotten worse or has spread to other parts of the body (metastatic), in combination with:

  • an aromatase inhibitor as the first endocrine-based therapy; or...